Apoptotic proteins: p53 and c-myc related pathways

Cardiology Clinics

Volumn 19, Issue 1, 2001, Pages 75-89

  McCarthy, Nicola ^b   Mercer, John ^b   Bennett, Martin ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSIS INDUCING FACTOR; APOPTOTIC PROTEIN; PROTEIN P53; UNCLASSIFIED DRUG;

APOPTOSIS; ATHEROSCLEROSIS; CELL PROLIFERATION; HEART MUSCLE CELL; HUMAN; NONHUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; REVIEW; TUMOR SUPPRESSOR GENE; VASCULAR DISEASE; VASCULAR SMOOTH MUSCLE;

EID: 0035031163     PISSN: 07338651     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0733-8651(05)70196-X     Document Type: Article

References (145)

1. B. Amati T.D. Littlewood G.L. Evan The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max EMBO J 12 1993 5083 5087
2. M. Aoki R. Morishita H. Matsushita Importance of p53-bax mediated apoptosis in the regulation of human vascular smooth muscle cells Hypertension 30 1997 189 P189
3. D. Askew R. Ashmun B. Simmons Constitutive c- myc expression in IL-3–dependent myeloid cell lines suppresses cycle arrest and accelerates apoptosis Oncogene 6 1991 1915 1922
4. D.E. Ayer L. Kretzner R.N. Eisenman Mad: A heterodimeric partner for Max that antagonises Myc transcriptional activity Cell 72 1993 211 222
5. H.Z. Bai M.J. Pollman Y. Inishi Regulation of vascular smooth muscle cell apoptosis: Modulation of bad by a phosphatidylinositol 3-kinase-dependent pathway Circ Res 85 1999 229 237
6. Y. Barak T. Juven R. Haffner mdm2 expression is induced by wild type p53 activity EMBO J 12 1993 461 468
7. G. Baumann U. Heinzman H. Wagner Functional p53 is required for the bax-mediated apoptosis of osteoblastic cells J Bone Mineral Res 12 1997 F233 F233
8. Bauters C. de Groote P. M. Adamantidis Proto-oncogene expression in rabbit aorta after wall injury: First marker of the cellular process leading to restenosis after angioplasty? Eur Heart J 13 1992 556 559
9. R.E. Bellas S. GE Nuclear factor κB cooperates with c-Myc in promoting murine hepatocyte survival in a manner independent of p53 tumor suppressor function Cell Growth Diffen 10 1999 287 294
10. C. Bello-Fernandez J.L. Cleveland c-Myc transactivates the ornithine decarboxylase gene Curr Top Microbiol Immunol 182 1992 445 452
11. C. Beltinger S. Fulda T. Kammertoens Herpes simplex virus thymidine kinase/ganciclovir-induced apoptosis involves ligand-independent death receptor aggregation and activation of caspases Porc Natl Acad Sci U S A 96 1999 8699 8704
12. M. Bennett G. Evan A. Newby Central role of the c- myc proto-oncogene in vascular smooth muscle cell proliferation and cell death Br Heart J 69 1993 57
13. M. Bennett V. Lindner D. DeBlois Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery Art Thromb 17 1996 2326 2332
14. M. Bennett K. Macdonald Chan S.-W. Cell surface trafficking of Fas: A rapid mechanism of p53-mediated apoptosis Science 282 1998 290 293
15. M. Bennett K. Macdonald Chan S.-W. Fas, p53 and apoptosis Science 284 1999 1431b 1432b
16. M.R. Bennett S. Anglin J.R. McEwan Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c- myc antisense oligodeoxynucleotides J Clin Invest 93 1994 820 828
17. M.R. Bennett G.I. Evan S.M. Schwartz Apoptosis of human vascular smooth muscle cells derived from normal vessels and coronary atherosclerotic plaques J Clin Invest 95 1995 2266 2274
18. M.R. Bennett G.I. Evan Schwartz S.M. Apoptosis of rat vascular smooth muscle cells is regulated by p53-dependent and -independent pathways Circ Res 77 1995 266 273
19. M.R. Bennett T.D. Littlewood D.C. Hancock Downregulation of the c- myc proto-oncogene: A signal for vascular smooth muscle cell arrest? Biochem J 302 1994 701 709
20. M.R. Bennett T.D. Littlewood S.M. Schwartz Increased sensitivity of human vascular smooth muscle cells from atherosclerotic plaque to p53-mediated apoptosis Circ Res 81 1997 591 599
21. M.R. Bennett K. Macdonald Chan S.-W. Cooperative interactions between RB and p53 regulate cell proliferation, cell senescence, and apoptosis in human vascular smooth muscle cells from atherosclerotic plaques Circ Res 82 1998 704 712
22. S. Biro Y. Fu Z. Yu Antisense oligonucleotides targetting the mRNA encoding c-myc inhibits smooth muscle cell proliferation and migration [abstract] Clinical Res 40 1992 192
23. R. Bissonnette F. Echeverri A. Mahboubi Apoptotic cell death induced by c- myc is inhibited by bcl -2 Nature 359 1992 552 554
24. T. Blackwell L. Kretzner E. Blackwood Sequence-specific DNA binding of the c-Myc protein Science 250 1990 1149 1151
25. E. Blackwood R. Eisenmann Max: A helix-loop helix zipper protein that forms a sequence-specific DNA-binding complex with Myc Science 251 1991 1211 1217
26. E. Blackwood B. Luscher R. Eisenmann Myc and max associate in vivo Genes Dev 6 1992 71 80
27. C. Bouchard K. Thieke A. Maier Direct induction of Cylin D2 by myc contributes to cell cycle progression and sequestration of p27 EMBO J 18 1999 5321 5331
28. J.J. Boyle D.E. Bowyer P.L. Weissberg Fas-ligand/fas interactions mediate a component of macrophage induced vascular smooth muscle cell apoptosis J Path 187 1999 A16
29. J.J. Boyle D.E. Bowyer P.L. Weissberg Interactions between TNF κ and nitric oxide in human macrophage–induced vascular smooth muscle cell apoptosis J Path 187 1999 A12
30. L. Brown N. McCarthy DNA repair: A sense-abl response? Nature 387 1997 450 451
31. S. Burma A. Kurimasa G. Xie DNA-dependent protein kinase-independent activation of p53 in response to DNA damage J Biol Chem 274 1999 17139 17143
32. C. Caelles A. Helmberg M. Karin p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes Nature 370 1994 220 223
33. S. Calmels P. Hainaut H. Ohshima Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein Cancer Res, 57 1997 3365 3369
34. M. Cardone N. Roy H. Stennicke Regulation of cell death protease caspase 9 by phosphorylation Science 282 1998 1318 1321
35. A. Chinnaiyan C. Tepper M. Seldin FADD/mort1 is a common mediator of CD95 (Fas/Apo-1) and tumor necrosis factor receptor induced apoptosis J Biol Chem 271 1996 4961 4965
36. A.R. Clarke E.R. Maandag van Roon M. Requirement for a functional Rb-1 gene in murine development Nature 359 1992 328 330
37. F. Colotta N. Polentarutti M. Sironi Expression and involvement of c-fos and c-jun protooncogenes in programmed cell death induced by growth factor deprivation in lymphoid cell lines J Biol Chem 267 1992 18278 18283
38. T. Crook N.J. Marston E.A. Sara Transcriptional activation by p53 correlates with suppression of growth but not transformation Cell 79 1994 817 827
39. C.V. Dang L.M. Resar E. Emison Function of the c-Myc oncogenic transcription factor Exp Cell Res 253 1999 63 77
40. M. Dean R.A. Levine W. Ran Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact J Biol Chem 261 1986 9161 9166
41. R.A. DePhino N. Schreiber-Agus F.W. Alt Myc family oncogenes in the development of normal and neoplastic cells Adv Cancer Res 57 1991 1 46
42. L.A. Donehower M. Harvey B.L. Slagle Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours Nature 356 1992 215 221
43. G.F. Draetta Mammalian G1 cyclins Curr Opin Cell Biol 6 1994 842 846
44. M. Eilers S. Schirm J.M. Bishop The MYC protein activates transcription of the α-prothymosin gene EMBO J 10 1991 133 141
45. C.M. Eischen J. Weber M.F. Roussel Disruption of the ARF-Mdm2-p53 tumour suppressor pathway in Myc-induced lymphomagenesis Genes Dev 13 1999 2658 2669
46. el Deiry W.S. J.W. Harper P.M. O'Connor WAF1/CIP1 is induced in p53-mediated G1 arrest and apoptosis Cancer Res 54 1994 1169 1174
47. G. Evan L. Brown M. Whyte Apoptosis and the cell-cycle Curr Opin Cell Biol 7 1995 825 834
48. G. Evan E. Harrington A. Fanidi Integrated control of cell proliferation and cell death by the c-myc oncogene Philos Trans R Soc Lond Biol 345 1994 269 275
49. G. Evan T. Littlewood The role of c- myc in cell growth Curr Opin Genet Dev 3 1993 44 49
50. G. Evan T. Littlewood A matter of life and cell death Science 281 1998 1317 1322
51. G.I. Evan J.P. Moore J.M. Ibson Immunological probes in the analysis of myc protein expression Curr Top Microbiol Immunol 141 1988 189 201
52. G.I. Evan A.H. Wyllie C.S. Gilbert Induction of apoptosis in fibroblasts by c-myc protein Cell 69 1992 119 128
53. Fan S. el D.W.S. I. Bae p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents Cancer Res 54 1994 5824 5830
54. A. Fanidi E. Harrington G. Evan Cooperative interaction between c- myc and bcl -2 proto-oncogenes Nature 359 1992 554 556
55. C. Featherstone S. Jackson DNA-dependent protein kinase gets a break: Its role in repairing DNA and maintaining genomic integrity Br J Cancer 80 suppl 1 1999 14 19
56. D.W. Felsher J.M. Bishop Reversible tumourigenesis by MYC in haemopoietic lineages Mol Cell 4 1999 199 207
57. P. Friedlander Y. Haupt C. Prives A mutant p53 that discriminates between p53-responsive genes cannot induce apoptosis Mol Cell Biol 16 1996 4961 4971
58. C. Friesen I. Herr P.H. Krammer Involvement of the CD95 (APO-1/FAS) receptor/ligand system in drug-induced apoptosis in leukemia cells Nat Med 2 1996 574 577
59. S. Fulda M. Los C. Friesen Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system Int J Cancer 76 1998 105 114
60. J. Gong A. Costanzo Yang H.-Q. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage Nature 399 1999 806 809
61. D. Gordon M.A. Reidy E.P. Benditt Cell proliferation in human coronary arteries Proc Natl Acad Sci U S A 87 1990 4600 4460
62. Guevara N. Kim H.-S. E. Antonova The absence of p53 accelerates atherosclerosis by increasing cell proliferation in vivo Nature Med 5 1999 335 339
63. H. Hagiyama T. Adachi T. Yoshida Signaling through the antigen receptor of B lymphocytes activates a p53-independent pathway of c-Myc-induced apoptosis Oncogene 1999 1999 4091 4098
64. P. Hainaut T. Soussi B. Shomer Database of p53 gene somatic mutations in human tumors and cell lines: Updated compilation and future prospects Nuc Acids Res 25 1997 151 157
65. J.W. Harper G.R. Adami N. Wei The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases Cell 75 1993 805 816
66. E.A. Harrington M.R. Bennett A. Fanidi c-Myc induced apoptosis in fibroblasts is inhibited by specific cytokines EMBO J 13 1994 3286 3295
67. H. Hermeking D. Eick Mediation of c-Myc-induced apoptosis by p53 Science 265 1994 2091 2093
68. A.O. Hueber G.I. Evan Traps to catch unwary oncogenes Trends Genet 14 1998 364 367
69. A.O. Hueber M. Zornig D. Lyon Requirement for the CD95 receptor-ligand pathway in c- myc -induced apoptosis Science 278 1997 1305 1309
70. B. Iacopetta S. Wysocki P. Norman The p53 tumour suppressor gene is overexpressed but not mutated in human atherosclerotic tissue Int J Oncol 7 1995 399 402
71. C. Ihling T. Szombathy K. Nampoothiri Cystic medial degeneration of the aorta is associated with p53 accumulation, Bax upregulation, apoptotic cell death, and cell proliferation Heart 82 1999 286 293
72. T. Jacks A. Fazeli E.M. Schmitt Effects of an Rb mutation in the mouse Nature 359 1992 295 300
73. J.J.L. Jacobs B. Scheijen Voncken J.-W. Bmi-1 collaborates with c-Myc in tumourigenesis by inhibiting c-Myc-induced apoptosis INK4a/ARF Genes Dev 13 1999 2678 2690
74. G.S. Jimenez F. Bryntesson M.I. Torres-Arzayus DNA-dependent protein kinase is not required for the p53-dependent response to DNA damage Nature 400 1999 81 83
75. C.A. Jost M.C. Marin Kaelin W.G. p73 is a human p53-related protein that can induce apoptosis Nature 389 1997 191 194
76. P. Juin A.O. Hueber T. Littlewood c-Myc-induced sensitization to apoptosis is mediated through cytochrome c release Genes Dev 13 1999 1367 1381
77. Kaelin W.G. Jr The p53 gene family Oncogene 18 1999 7701 7705
78. J. Karlseder D. Broccoli Y.M. Dai p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2 Science 283 1999 1321 1325
79. M. Kastan Q. Zhan el Deiry W. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia Cell 71 1992 587 597
80. 3K and PKB Nature 385 1997 544 548
81. R. Khosravi R. Maya T. Gottlieb Rapid ATM-dependent phosphorylation of MDM2 precedes p53 accumulation in response to DNA damage Proc Natl Acad Sci U S A 96 1999 14973 14977
82. M. Kubbutat S.N. Jones K.H. Vousden Regulation of p53 stability by Mdm2 Nature 387 1997 299 303
83. D.P. Lane Cancer. p53, guardian of the genome Nature 358 1992 15 16
84. E.Y. Lee C.Y. Chang N. Hu Mice deficient for Rb are non-viable and show defects in neurogenesis and haematopoiesis Nature 359 1992 288 294
85. J.M. Lee A. Bernstein p53 mutations increase resistance to ionizing radiation Proc Natl Acad Sci U S A 90 1993 5742 5746
86. A.J. Levine p53, the cellular gatekeeper for growth and division Cell 88 1997 323 331
87. P.F. Li R. Dietz von Harsdorf R. p53 regulates mitochondrial membrane potential through reactive oxygen species and induces cytochrome c-independent apoptosis blocked by Bcl-2 EMBO J 18 1999 6027 6036
88. T.D. Littlewood G.I. Evan Transcription Factor 2: Helix-loop-helix Protein Profiles 2 1995 621 654
89. X. Liu X. Zhu Roles of p53, c-Myc, Bcl-2, Bax and caspases in serum deprivation-induced neuronal apoptosis: A possible neuroprotective mechanism of basic fibroblast growth factor Neuroreport 10 1999 3087 3091
90. A. LopezCandales D.R. Holmes S.X. Liao Decreased vascular smooth muscle cell density in medial degeneration of human abdominal aortic aneurysms Am J Pathol 150 1997 993 1007
91. J.P. Medema C. Scaffidi F.C. Kischkel FLICE is activated by association with the CD95 death-inducing signaling complex (DISC) EMBO J 16 1997 2794 2804
92. J.M. Miano R.R. Tota N. Vlasic Early proto-oncogene expression in rat aortic smooth muscle cells following endothelial removal Am J Pathol 137 1990 761 765
93. A. Mills B. Zheng Wang X.-J. p63 is a p53 homologue required for limb and epidermal morphogenesis Nature 708 1999 708 713
94. T. Miyashita J. Reed Tumor suppressor gene p53 is a direct transcriptional activator of the human Bax gene Cell 80 1995 293 299
95. M. Mueller S. Strand H. Hug Chemotherapy-induced p53 accumulation in hepg2 cells results in induction of cd95 (apo-1/fas) receptor and ligand followed by apoptosis Gastroenterology 110 1996 A563
96. D. Muller C. Bouchard B. Ruldolph Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes Oncogene 15 1997 2561 2576
97. M. Muller S. Wilder D. Bannasch p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs J Exp Med 188 1998 2033 2045
98. D. Munsch R. Watanabe-Fukunaga J.C. Bourdon Human and mouse Fas (APO-1/CD95) death receptor genes each contain a p53-responsive element that is activated by p53 mutants unable to induce apoptosis J Biol Chem 275 2000 3867 3872
99. K. Newton A. Strasser Ionizing radiation and chemotherapeutic drugs induce apoptosis in lymphocytes in the absence of Fas or FADD/MORT1 signaling. Implications for cancer therapy J Exp Med 191 2000 195 200
100. R. O'Connor A. Kaufmann-Zeh Y.M. Liu Identification of domains of the insulin-like growth factor I receptor that are required for protection from apoptosis Mol Cellular Biol 17 1997 427 435
101. G.H. Pan E.W. Humke V.M. Dixit Activation of caspases triggered by cytochrome c in vitro FEBS Lett 426 1998 151 154
102. G.H. Pan K. ORourke V.M. Dixit Caspase-9, Bcl-xL, and Apaf-1 form a ternary complex J Biol Chem 273 1998 5841 5845
103. H.C. Pan C.Y. Yin N.J. Dyson Key roles for E2F1 in signaling p53-dependent apoptosis and in cell division within developing tumors Mol Cell 2 1998 283 292
104. J.L. Parkes R.R. Cardell F.C. Hubbard Cultured human atherosclerotic plaque smooth muscle cells retain transforming potential and display enhanced expression of the myc protooncogene Am J Pathol 138 1991 765 775
105. S. Pelengaris T. Littlewood M. Khan Reversible activation of c-Myc in skin. Induction of a complex neoplastic phenotype by a single oncogenic lesion Mol Cell 3 1999 565 577
106. S. Pelengaris B. Ruldolf T.D. Littlewood Action of Myc in vivo: proliferation and apoptosis Curr Opin Genes Dev 10 2000 100 105
107. I. Perez-Roger S.H. Kim B. Griffiths Cyclins D1 and D2 mediate myc-induced proliferation via sequestration of p27 (Kip1) and p21 (Cip 1) EMBO J 18 1999 5310 5320
108. S.M. Picksley D.P. Lane p53 and Rb: their cellular roles Curr Opin Cell Biol 6 1994 853 858
109. K. Polyak Y. Xia J.L. Zweier A model for p53-induced apoptosis Nature 389 1997 300 305
110. M.C. Raff Social controls on cell survival and cell death Nature 356 1992 397 400
111. A. Rehemtulla C.A. Hamilton A.M. Chinnaiyan Ultraviolet radiation-induced apoptosis is mediated by activation of CD-95 (Fas/APO-1) J Biol Chem 272 1997 25783 25786
112. D. Reisman N.B. Elkind B. Roy c-Myc trans-activates the p53 promoter through a required downstream CACGTG motif Cell Growth Differ 4 1993 57 65
113. J.L. Rohn A.O. Hueber N.J. McCarthy The opposing roles of the Akt and c-Myc signalling pathways in survival from CD95-mediated apoptosis Oncogene 17 1998 2811 2818
114. R. Ross T.N. Wight E. Strandness Human atherosclerosis. I. Cell constitution and characteristics of advanced lesions of the superficial femoral artery Am J Pathol 114 1984 79 93
115. S. Rowan R. Ludwig Y. Haupt Specific loss of apoptotic but not cell cycle arrest function in a human tumor-derived p53 mutant EMBO J 15 1996 827 838
116. B. Roy J. Beamon E. Balint Transactivation of the human p53 tumor suppressor gene by c-Myc/Max contributes to elevated mutant p53 expression in some tumors Mol Cell Biol 14 1994 7805 7815
117. K.M. Ryan K.H. Vousden Characterization of structural p53 mutants which show selective defects in apoptosis but not cell cycle arrest Mol Cellular Biol 18 1998 3692 3698
118. M. Scheinman E. Ascher G.S. Levi p53 gene transfer to the injured rat carotid artery decreases neointimal formation J Vascular Surgery 29 1999 360 369
119. C.A. Schmitt M.E. McCurrach de Stanchina E. INK4a/ARF mutations accelerate lymphomagenesis and promote chemoresistance by disabling p53 Genes Dev 13 1999 2670 2677
120. D. Schwartz V. Rotter p53-dependent cell cycle control: response to genotoxic stress Sem Cancer Biol 8 1998 325 336
121. C.J. Sherr J.D. Webber The ARF/p53 pathway Curr Opin Genet Dev 10 2000 94 99
122. Y. Shi A. Fard A. Galeo Transcatheter delivery of c-myc antisense oligomers reduces neointimal formation in a porcine model of coronary artery balloon injury Circulation 90 1994 944 951
123. Y. Shi J. Glynn L. Guilbert Role for c- myc in activation-induced apoptotic cell death in T cell hybridomas Science 257 1992 212 214
124. Y. Shi H. Hutchison D. Hall Downregulation of c- myc expression by antisense oligonucleotides inhibits proliferation of human smooth muscle cells Circulation 88 1993 1190 1195
125. W.J. Slichenmeyer W.G. Nelson R.J. Slebos Loss of a p53-associated G1 checkpoint does not decrease cell survival following DNA damage Cancer Res 53 1993 4164 4168
126. T. Soussi Y. Legros R. Lubin Multifactorial analysis of p53 alteration in human cancer – a review Int J Cancer 57 1994 1 9
127. E. Speir R. Modali E.S. Huang Potential role of human cytomegalovirus and p53 interaction in coronary restenosis Science 265 1994 391 394
128. E. Stenger G. Mayr K. Mann Formation of stable p53 homotetramers and multiples of tetramers Mol Carcinogen 5 1992 102 106
129. R.W. Thompson S.X. Liao J.A. Curci Vascular smooth muscle cell apoptosis in abdominal aortic aneurysms Coronary Artery Disease 8 1997 623 631
130. M. Trudel J. Lanoix L. Barisoni C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent J Exp Med 186 1997 1873 1884
131. R.L. Waikel X.L. Wang D.R. Roop Targeted expression of c-Myc in the epidermis alters normal proliferation, differentiation and UV-induced apoptosis Oncogene 18 1999 4870 4878
132. X.W. Wang Q.M. Zhan J.D. Coursen GADD45 induction of a G(2)/M cell cycle checkpoint Proc Natl Acad Sci U S A 96 1999 3706 3711
133. M.J.F. Waterman E.S. Stavridi J.L.F. Waterman ATM-dependent activation of p53 involves dephosphorylation and association with 14–3–3 proteins Nature Genet 19 1998 175 178
134. E. White Regulation of p53-dependent apoptosis by members of the Bcl-2 family Molecular Biology of the Cell 7 1996 2936 2936
135. G.T. Williams C.A. Smith E. Spooncer Haemopoietic colony stimulating factors promote cell survival by suppressing apoptosis Nature 343 1990 76 79
136. G.S. Wu T.F. Burns E.R. McDonald KILLER/DR5 is a DNA damage-inducible p53-regulated death receptor gene Nature Genetics 17 1997 141 143
137. G.S. Wu K. Kim W.S. El-Deiry Killer/DR5, a novel DNA-damage inducible death receptor gene, links the p53 tumor suppressor to caspase activation and apoptotic death Adv Exp Med Biol 465 2000 143 151
138. X. Wu J.H. Bayle D. Olson The p53-mdm-2 autoregulatory feedback loop Genes Dev 7 1993 1126 1132
139. Y. Xiong G.J. Hannon H. Zhang p21 is a universal inhibitor of cyclin kinases [see comments] Nature 366 1993 701 704
140. A.N. Yang M. Kaghad Y.M. Wang p63, a p53 homolog at 3q27–29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities Mol Cell 2 1998 305 316
141. Y. Yonemitsu Y. Kaneda S. Tanaka Transfer of wild-type p53 gene effectively inhibits vascular smooth muscle cell proliferation in vitro and in vivo Circ Res 82 1998 147 156
142. Yuan Z.-M. H. Shioya T. Ishiko p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage Nature 399 1999 814 817
143. A. Zervos L. Faccio J. Gatto Mxi2, a mitogen-activated protein-kinase that recognizes and phosphorylates Max protein Proc Natl Acad Sci U S A 9 1995 10531 10534
144. J.H. Zhu J.Y. Jiang W.J. Zhou Differential regulation of cellular target genes by p53 devoid of the PXXP motifs with impaired apoptotic activity Oncogene 18 1999 2149 2155
145. F. Zindy C.M. Eischen D.H. Randle Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization Genes & Dev 12 1998 2424 2433